Khalid Bin Dhuban
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Khalid Bin Dhuban has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Ciriaco A. Piccirillo
Department of Microbiology and Immunology, McGill University, Montréal, Québec, Canada
5 shared publications Bruce Mazer
Division of Pediatric Allergy and Clinical Immunology, Department of Pediatrics, McGill University Health Center, Montréal, Québec H3H 1P3, Canada
2 shared publicationsEva D'HEnnezel
Department of Microbiology and Immunology and FOCIS Center of Excellence McGill University and the Research Institute
2 shared publicationsMoshe Ben-Shoshan
Division of Pediatric Allergy and Clinical Immunology, Department of Pediatrics, McGill University Health Center, Montréal, Québec H3H 1P3, Canada
2 shared publicationsAlan Berezov
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104-6082, USA
1 shared publicationAmit Bar-Or
Neuroimmunology Unit, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec H3A 2B4, Canada
1 shared publication
Latest Publications
- 9 June 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 2 (12)
Suppression by human FOXP3 + regulatory T cells requires FOXP3-TIP60 interactions
Targeting the FOXP3-TIP60 interaction may modulate T reg activity in IPEX and other autoimmune and inflammatory diseases.
- 9 June 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 2 (12)
Suppression by human FOXP3 + regulatory T cells requires FOXP3-TIP60 interactions
Targeting the FOXP3-TIP60 interaction may modulate T reg activity in IPEX and other autoimmune and inflammatory diseases.
- 1 December 2015
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 15 (6) , 525-532
The immunological and genetic basis of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome
This article presents a comprehensive review of the immunodysregulation, polyendocrinopathy, enteropathy and X-linked (IPEX) syndrome, covering both the clinical and molecular aspects of the disease. (Figure is included in full-text article.) The IPEX syndrome is a rare immunological disorder in humans caused by inheritable mutations in the FOXP3 gene, the master transcriptional regulator for the development and function of CD4 regulatory T (Treg) cells. Forkhead box protein 3 (FOXP3) Treg cells represent a unique T-cell lineage with inhibitory functions, and are responsible for immune homeostasis and tolerance to self and nonself antigens. Evidence shows that a Treg developmental deficiency or dysfunction underlies the severe, multiorgan, autoimmune disease of IPEX. An in-depth structural and functional analysis of the molecular domains of FOXP3 is essential for our understanding of the observed clinical heterogeneity and prognosis in IPEX.
- 1 December 2015
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 15 (6) , 525-532
The immunological and genetic basis of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome
This article presents a comprehensive review of the immunodysregulation, polyendocrinopathy, enteropathy and X-linked (IPEX) syndrome, covering both the clinical and molecular aspects of the disease. (Figure is included in full-text article.) The IPEX syndrome is a rare immunological disorder in humans caused by inheritable mutations in the FOXP3 gene, the master transcriptional regulator for the development and function of CD4 regulatory T (Treg) cells. Forkhead box protein 3 (FOXP3) Treg cells represent a unique T-cell lineage with inhibitory functions, and are responsible for immune homeostasis and tolerance to self and nonself antigens. Evidence shows that a Treg developmental deficiency or dysfunction underlies the severe, multiorgan, autoimmune disease of IPEX. An in-depth structural and functional analysis of the molecular domains of FOXP3 is essential for our understanding of the observed clinical heterogeneity and prognosis in IPEX.
- 14 September 2015
- Published by Wiley
- p. 1-5
Molecular Genetics of the IPEX Syndrome
- 15 April 2015
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 194 (8) , 3687-3696
Coexpression of TIGIT and FCRL3 Identifies Helios+ Human Memory Regulatory T Cells
Two distinct subsets of CD4+Foxp3+ regulatory T (Treg) cells have been described based on the differential expression of Helios, a transcription factor of the Ikaros family. Efforts to understand the origin and biological roles of these Treg populations in regulating immune responses have, however, been hindered by the lack of reliable surface markers to distinguish and isolate them for subsequent functional studies. Using a single-cell cloning strategy coupled with microarray analysis of different Treg functional subsets in humans, we identify the mRNA and protein expression of TIGIT and FCRL3 as a novel surface marker combination that distinguishes Helios+FOXP3+ from Helios−FOXP3+ memory cells. Unlike conventional markers that are modulated on conventional T cells upon activation, we show that the TIGIT/FCRL3 combination allows reliable identification of Helios+ Treg cells even in highly activated conditions in vitro as well as in PBMCs of autoimmune patients. We also demonstrate that the Helios−FOXP3+ Treg subpopulation harbors a larger proportion of nonsuppressive clones compared with the Helios+FOXP3+ cell subset, which is highly enriched for suppressive clones. Moreover, we find that Helios− cells are exclusively responsible for the productions of the inflammatory cytokines IFN-γ, IL-2, and IL-17 in FOXP3+ cells ex vivo, highlighting important functional differences between Helios+ and Helios− Treg cells. Thus, we identify novel surface markers for the consistent identification and isolation of Helios+ and Helios− memory Treg cells in health and disease, and we further reveal functional differences between these two populations. These new markers should facilitate further elucidation of the functional roles of Helios-based Treg heterogeneity.
- 15 April 2015
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 194 (8) , 3687-3696
Coexpression of TIGIT and FCRL3 Identifies Helios+ Human Memory Regulatory T Cells
Two distinct subsets of CD4+Foxp3+ regulatory T (Treg) cells have been described based on the differential expression of Helios, a transcription factor of the Ikaros family. Efforts to understand the origin and biological roles of these Treg populations in regulating immune responses have, however, been hindered by the lack of reliable surface markers to distinguish and isolate them for subsequent functional studies. Using a single-cell cloning strategy coupled with microarray analysis of different Treg functional subsets in humans, we identify the mRNA and protein expression of TIGIT and FCRL3 as a novel surface marker combination that distinguishes Helios+FOXP3+ from Helios−FOXP3+ memory cells. Unlike conventional markers that are modulated on conventional T cells upon activation, we show that the TIGIT/FCRL3 combination allows reliable identification of Helios+ Treg cells even in highly activated conditions in vitro as well as in PBMCs of autoimmune patients. We also demonstrate that the Helios−FOXP3+ Treg subpopulation harbors a larger proportion of nonsuppressive clones compared with the Helios+FOXP3+ cell subset, which is highly enriched for suppressive clones. Moreover, we find that Helios− cells are exclusively responsible for the productions of the inflammatory cytokines IFN-γ, IL-2, and IL-17 in FOXP3+ cells ex vivo, highlighting important functional differences between Helios+ and Helios− Treg cells. Thus, we identify novel surface markers for the consistent identification and isolation of Helios+ and Helios− memory Treg cells in health and disease, and we further reveal functional differences between these two populations. These new markers should facilitate further elucidation of the functional roles of Helios-based Treg heterogeneity.
- 9 April 2014
- Published by Wiley in Immunological Reviews
- Vol. 259 (1) , 140-158
Functional dynamics of Foxp3+ regulatory T cells in mice and humans
Summary: Forkhead box protein 3 (Foxp3)+ regulatory T (Treg) cells are critical mediators for the establishment of self‐tolerance and immune homeostasis and for the control of pathology in various inflammatory responses. While Foxp3+ Treg cells often control immune responses in secondary lymphoid tissues, they must also traffic to and persist within non‐lymphoid tissues, where they integrate various environmental cues to coordinate and adapt their effector acitvities in these sites. In recent years, our group has made use of several mouse models, including the non‐obese diabetic model of type 1 diabetes, to characterize the factors, which impact the homeostasis, function, and reprogramming potential of Foxp3+ Treg cells in situ. In addition, our recent work shows that Foxp3+ Treg cells possess distinct post‐transcriptional mechanisms of gene regulation, namely mRNA translation, to modulate tissue‐specific inflammatory responses. In humans, there is a pressing need for reliable markers of FOXP3+ Treg cells and their related function in blood and tissue. Experimental progress in our group has enabled us to discover novel markers of FOXP3+ Treg cell (dys)function and unique gene signatures that discriminate effector and Treg cells, as well as functional and dysfunctional FOXP3+ Treg cells.
- 9 April 2014
- Published by Wiley in Immunological Reviews
- Vol. 259 (1) , 140-158
Functional dynamics of Foxp3+ regulatory T cells in mice and humans
Summary: Forkhead box protein 3 (Foxp3)+ regulatory T (Treg) cells are critical mediators for the establishment of self‐tolerance and immune homeostasis and for the control of pathology in various inflammatory responses. While Foxp3+ Treg cells often control immune responses in secondary lymphoid tissues, they must also traffic to and persist within non‐lymphoid tissues, where they integrate various environmental cues to coordinate and adapt their effector acitvities in these sites. In recent years, our group has made use of several mouse models, including the non‐obese diabetic model of type 1 diabetes, to characterize the factors, which impact the homeostasis, function, and reprogramming potential of Foxp3+ Treg cells in situ. In addition, our recent work shows that Foxp3+ Treg cells possess distinct post‐transcriptional mechanisms of gene regulation, namely mRNA translation, to modulate tissue‐specific inflammatory responses. In humans, there is a pressing need for reliable markers of FOXP3+ Treg cells and their related function in blood and tissue. Experimental progress in our group has enabled us to discover novel markers of FOXP3+ Treg cell (dys)function and unique gene signatures that discriminate effector and Treg cells, as well as functional and dysfunctional FOXP3+ Treg cells.
- Open Access
- 25 October 2013
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 162 (4) , 318-322
Altered T Helper 17 Responses in Children with Food Allergy
Background: While a central role for the T helper (Th) 1/Th2 axis in food allergy has been established, the Th17 response in food-allergic humans has not been addressed. Methods: Th17 responses in 18 peanut-allergic children, who were also allergic to at least one additional food allergen, were assessed relative to 15 age-matched healthy controls. To account for the atopy background in the allergic children, 7 atopic, but not food-allergic, individuals and their age-matched controls were included in this study. PBMCs were analyzed by flow cytometry ex vivo or were stimulated in vitro with peanut allergens, gliadin, or tetanus toxoid followed by analysis of proliferation and cytokine production in antigen-responsive cells. Results: We observed a significantly lower interleukin (IL) 17 production in CD4+ T cells of food-allergic individuals ex vivo (p < 0.02). In vitro, we found that IL-17 production in CD4+ T cells in response to all antigens tested was significantly impaired in food-allergic subjects compared to healthy controls (Ara: p < 0.005; gliadin: p < 0.004; TT: p < 0.03). No significant differences were observed between atopic and nonatopic individuals with no food allergy. Conclusion: Our results thus reveal a systemic, non-allergen-specific defect in Th17 responses to antigen stimulation in food allergic individuals, suggesting a role for Th17 cells in the control of food allergy and implicating IL-17 as a potential biomarker for tolerance to food antigens.
- 25 October 2013
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 162 (4) , 318-322
Open AccessAltered T Helper 17 Responses in Children with Food Allergy
Background: While a central role for the T helper (Th) 1/Th2 axis in food allergy has been established, the Th17 response in food-allergic humans has not been addressed. Methods: Th17 responses in 18 peanut-allergic children, who were also allergic to at least one additional food allergen, were assessed relative to 15 age-matched healthy controls. To account for the atopy background in the allergic children, 7 atopic, but not food-allergic, individuals and their age-matched controls were included in this study. PBMCs were analyzed by flow cytometry ex vivo or were stimulated in vitro with peanut allergens, gliadin, or tetanus toxoid followed by analysis of proliferation and cytokine production in antigen-responsive cells. Results: We observed a significantly lower interleukin (IL) 17 production in CD4+ T cells of food-allergic individuals ex vivo (p < 0.02). In vitro, we found that IL-17 production in CD4+ T cells in response to all antigens tested was significantly impaired in food-allergic subjects compared to healthy controls (Ara: p < 0.005; gliadin: p < 0.004; TT: p < 0.03). No significant differences were observed between atopic and nonatopic individuals with no food allergy. Conclusion: Our results thus reveal a systemic, non-allergen-specific defect in Th17 responses to antigen stimulation in food allergic individuals, suggesting a role for Th17 cells in the control of food allergy and implicating IL-17 as a potential biomarker for tolerance to food antigens.
- 11 May 2012
- Published by BMJ in Journal of Medical Genetics
- Vol. 49 (5) , 291-302
The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome
Immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome is a rare disorder in humans caused by germ-line mutations in the FOXP3 gene, a master transcriptional regulator for the development of CD4 regulatory T (Treg) cells. This T cell subset has global inhibitory functions that maintain immune homeostasis and mediate self-tolerance. Treg developmental deficiency or dysfunction is a hallmark of IPEX. It leads to severe, multi-organ, autoimmune phenomena including enteropathy, chronic dermatitis, endocrinopathy and other organ-specific diseases such as anaemia, thrombocytopenia, hepatitis and nephritis. In this review, the genetic, immunological and clinical characteristics of IPEX syndrome are described, and the impact of heritable mutations on the function of Treg cells highlighted.
- 11 May 2012
- Published by BMJ in Journal of Medical Genetics
- Vol. 49 (5) , 291-302
The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome
Immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome is a rare disorder in humans caused by germ-line mutations in the FOXP3 gene, a master transcriptional regulator for the development of CD4 regulatory T (Treg) cells. This T cell subset has global inhibitory functions that maintain immune homeostasis and mediate self-tolerance. Treg developmental deficiency or dysfunction is a hallmark of IPEX. It leads to severe, multi-organ, autoimmune phenomena including enteropathy, chronic dermatitis, endocrinopathy and other organ-specific diseases such as anaemia, thrombocytopenia, hepatitis and nephritis. In this review, the genetic, immunological and clinical characteristics of IPEX syndrome are described, and the impact of heritable mutations on the function of Treg cells highlighted.
- 1 January 2012
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 19 (1) , 109-112
Acquired Omenn-Like Syndrome, a Novel Posttransplant Autoaggression Syndrome Reversed by Rapamycin
Graft-versus-host disease is uncommon in autologous hematopoietic cell transplantation (HCT) and is typically brief and mild. We report unusual, protracted, and severe Omenn syndrome-like autoaggression following autologous HCT. We identified a profound FOXP3 + regulatory T cell defect that coincided with hyperinflammatory T cell responses which were reversible with rapamycin in vitro .
- 1 January 2012
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 19 (1) , 109-112
Acquired Omenn-Like Syndrome, a Novel Posttransplant Autoaggression Syndrome Reversed by Rapamycin
Graft-versus-host disease is uncommon in autologous hematopoietic cell transplantation (HCT) and is typically brief and mild. We report unusual, protracted, and severe Omenn syndrome-like autoaggression following autologous HCT. We identified a profound FOXP3 + regulatory T cell defect that coincided with hyperinflammatory T cell responses which were reversible with rapamycin in vitro .